HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Comparative study of the anti-arrhythmic activity of cardiocyclide and nibentan in hypersympathotonia and acute myocardial ischemia].

Abstract
The antiarrhythmogenic and antifibrillar action of cardiocyclide and nibentan--class III antiarrhythmogens (according to the classification of Vaughan Williams) was experimentally studied on narcotized cats. The hypersympathotonia model was induced by a 30-sec stimulation of the left stellate cervical ganglion on the background of acute myocardial infarction. On this model of a ventricular disorder in the heart rhythm, cardiocyclide (2.4 mg/kg) and nibentan (0.2 mg/kg) exhibited pronounced antiarrhythmic activity. It is suggested that both drugs can be used under clinical conditions for the prophylaxis of sudden coronary death in patents with acute myocardial infarction.
AuthorsM B Vititnova, S A Kryzhanovskiĭ, N V Kaverina
JournalEksperimental'naia i klinicheskaia farmakologiia (Eksp Klin Farmakol) 2002 Mar-Apr Vol. 65 Issue 2 Pg. 24-6 ISSN: 0869-2092 [Print] Russia (Federation)
Vernacular TitleSravnitel'noe izuchenie antiaritmicheskoĭ aktivnosti kardiotsiklida i nibentana v usloviiakh gipersimpatotonii i ostroĭ ishemii miokarda.
PMID12109286 (Publication Type: Journal Article)
Chemical References
  • Anti-Arrhythmia Agents
  • Benzamides
  • nibentan
Topics
  • Animals
  • Anti-Arrhythmia Agents (therapeutic use)
  • Arrhythmias, Cardiac (etiology, prevention & control)
  • Autonomic Nervous System Diseases (complications, physiopathology)
  • Benzamides (therapeutic use)
  • Cats
  • Electric Stimulation
  • Electrocardiography
  • Female
  • Male
  • Myocardial Ischemia (complications, physiopathology)
  • Stellate Ganglion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: